Drug Profile
DB 337
Latest Information Update: 16 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 16 Jun 2001 No-Development-Reported for Mycoses in Italy (Unknown route)
- 16 Jun 2001 No-Development-Reported for Mycoses in USA (Unknown route)
- 02 Feb 1998 Preclinical development for Mycoses in Italy (Unknown route)